The people behind Helix
Scientific Advisory Board

Wendy Chung, M.D., Ph.D.
Wendy Chung, M.D., Ph.D. is a clinical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine and Director of Clinical Genetics. Dr. Chung directs research programs in human genetics of obesity, breast cancer, pulmonary hypertension, autism, and more. She is a national leader in the ethical, legal, and social implications of genomics; leads the Precision Medicine Resource in the Irving Institute At Columbia University; and has served on the Institute of Medicine Committee on Genetic Testing.

Nita Farahany, J.D., Ph.D.
Nita Farahany, J.D., Ph.D. is Professor of Law and Philosophy, Director of Duke Science & Society at Duke University, and a member of the Presidential Commission for the Study of Bioethics. Her research focuses on how developments in behavioral genetics and neuroscience inform societal norms about privacy and individual liberty.

Judy Garber, M.D., MPH
Judy Garber, M.D., MPH is Professor of Medicine at Harvard Medical School and Director, Center for Cancer Genetics and Prevention at Dana Farber Cancer Institute. Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer.
Our Investors
Helix's mission is made possible by the generous support of our board of investors.





